Allogeneic stem cell transplantation is the only potentially curative treatment for various blood cancers. To cure, patients need YOU as donor of bone marrow or (much more frequently!) peripheral blood🙏 Register and be a real-world superhero! Share and save lives🙏 #WMDD23

Elevated B12 serum levels are associated with the presence of clonal hematopoiesis ow.ly/I6kU50WIUtw #myeloidneoplasia #clonalhematopoiesis

🚨 ¡Últimos días para postular al CRTI LA! 📅 Taller intensivo de investigación clínica (2 días) ⚠️ Postulación en inglés + fluidez requerida ✈️ Viaje y alojamiento cubiertos por ASH 📝 Aplique ya: hematology.org/crti-la #CRTI #CRTILA #Hematología #ASH

Towards a chemo-free approach for follicular lymphoma. British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…

🔴 September is #BloodCancerAwarenessMonth At EBMT, we join the global effort to increase public understanding of blood cancers and highlight the importance of early diagnosis. Through collaborative science and clinical expertise, we are committed to advancing research,

diariomedico.com/medicina/hemat…

#NewProfilePic

Today is World Leukaemia Day – another important occasion during #BloodCancerAwarenessMonth to raise awareness and support better patient outcomes. 🏥 💡 At EBMT, the Acute Leukaemia Working Party (ALWP) is dedicated to advancing research, improving transplant strategies, and

Are you ready to join us? 1st #ICOnic Artificial Intelligence in #HSCT #CARTcell GETH @sehh_es SEHH Joven The EBMT The EBMT Trainee Committee Anna Sureda Marta Peña Felipe Peña Muñoz Carol Garcia-Vidal Adrián Mosquera Orgueira Register for free! ⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️ e-oncologia.org/cursos/1st-day…

How does stem cell transplantation works? How does it ‘cure’ leukaemia? The answer is very interesting and why haematology is fascinating #ITCTC25 has kicked off

Great overview of CAR-T cell therapies by Alberto Mussetti #ITCTC25

Day 1️⃣ of #ITCTC25 has been fantastic, with plenty of opportunities to share, connect, and expand our knowledge in HCT and cellular therapies. 💡✍️ Before we wrap up the first day, we are looking forward to Alex Rampota's keynote and the Poster Session!

What a special weekend! 🔝 These past 3 days in 📍 Barcelona at #ITCTC25 have been extraordinary. A huge thank you to all our chairs, speakers and attendees for filling the venue and celebrating a decade of excellence and collaboration at this 10th milestone event. 🌍 📅 Save

This year was not possible for me to be there but I know all of you had a great time learning a lot! Safe trips back home and see you next year! #ITCTC26! The EBMT The EBMT Trainee Committee

Take a look at how the #EBMT Community spent its weekend in Barcelona at #ITCTC25 🎞️🤩 Thank you all for making these past three days an incredible experience full of science, education and networking. 📈🎤🤝 We cannot wait to be back in Barcelona for the 11th edition from 4-6

🆕 La #SEHH y la Fundación Josep Carreras contra la Leucemia fcarreras hemos firmado un convenio de cooperación científica. 🩸El objetivo es impulsar la formación de profesionales, organizar eventos científicos, compartir conocimiento y seguir avanzando en la investigación en

Out now in Haematologica 🎉 Not all HLA mismatches carry the same immunological risk, even in the PTCy era! Read our comment on the Sanz et al manuscript in this month's Haematologica 🙌🏽 haematologica.org/newsletter/v1/…

While the etiology of MM is considered multifactorial, in our recent study we estimate about 11-17% of MM cases may be attributable to excess BMI and 1.2% cases to DM. haematologica.org/article/view/1… #mmsm Haematologica International Myeloma Foundation Memorial Sloan Kettering Cancer Center

🌐#DiaMundialDelLinfoma | En 2026 se diagnosticarán 12.000 nuevos casos de #linfoma. Gracias a la #investigación e #innovación con terapias #CART podemos ofrecer una nueva oportunidad de curación a #pacientes en los que nos han funcionado tratamientos de quimioterapia #wlad2025

🧵 Superficial Vein Thrombosis (SuVT) — JAMA Review 2025 1️⃣ Definition & Incidence 🩸 Thrombus in superficial veins (lower/upper limbs) 📊 Incidence: 64–131 /100k person-years ⚠️ ~10% risk progression to DVT/PE 2️⃣ Pathophysiology 🔺 Virchow’s triad: endothelial injury,